Jafron Biomedical Co.,Ltd. (SHE:300529)
China
· Delayed Price · Currency is CNY 18.71
-0.27 (-1.42%)
At close: Mar 9, 2026
Jafron Biomedical Market Cap
Jafron Biomedical has a market cap or net worth of 14.49 billion as of March 9, 2026. Its market cap has decreased by -31.01% in one year.
Market Cap
14.49B
Enterprise Value
13.43B
Revenue
2.04B
Ranking
n/a
PE Ratio
29.72
Stock Price
18.71
Market Cap Chart
Since August 2, 2016, Jafron Biomedical's market cap has increased from 6.41B to 14.49B, an increase of 126.15%. That is a compound annual growth rate of 8.87%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Balance Medical Technology | 14.13B |
| Shandong Weigao Blood Purification Products | 16.11B |
| MeHow Innovative | 16.51B |
| Shanghai MicroPort Endovascular MedTech | 12.61B |
| Cofoe Medical Technology | 12.04B |
| Double Medical Technology | 17.98B |
| Shandong Weigao Orthopaedic Device | 11.74B |
| SonoScape Medical | 11.14B |